Quarterly report pursuant to Section 13 or 15(d)

Fair Value Measurements (Tables)

v3.19.2
Fair Value Measurements (Tables)
9 Months Ended
Jun. 29, 2019
Fair Value Disclosures [Abstract]  
Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis
The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis based upon the level within the fair value hierarchy in which the fair value measurements fall, as of June 29, 2019 (in thousands): 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
 
Short term investments (a)
 
$
119


$


$


$
119

Total assets
 
$
119


$


$


$
119

Liabilities:
 
 
 
 
 
 
 
 
Liability for contingent consideration (b)
 
$

 
$

 
$
7,824

 
$
7,824

Total liabilities
 
$

 
$

 
$
7,824

 
$
7,824

The following table presents the Company’s financial assets and liabilities measured at fair value on a recurring basis based upon the level within the fair value hierarchy in which the fair value measurements fall, as of June 30, 2018 (in thousands): 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Liabilities:
 
 
 
 
 
 
 
 
Liability for contingent consideration (b)
 
$

 
$

 
$
7,645

 
$
7,645

Total liabilities
 
$

 
$

 
$
7,645

 
$
7,645

The following table presents our financial assets and liabilities at fair value on a recurring basis based upon the level within the fair value hierarchy in which the fair value measurements fall, as of September 29, 2018: 
 
 
Level 1
 
Level 2
 
Level 3
 
Total
Liabilities:
 
 
 
 
 
 
 
 
Liability for contingent consideration (b)
 
$

 
$

 
$
8,224

 
$
8,224

Total liabilities
 
$

 
$

 
$
8,224

 
$
8,224

 
(a)
The fair value of short-term investments are based on quoted prices in active markets for identical assets.
(b)
The liability for contingent consideration relates to an earn-out for B2E, acquired in December 2012, future performance-based contingent payments for Hydro-Organics Wholesale, Inc., acquired in October 2015, future performance-based contingent payment for Segrest, Inc., acquired in October 2016, and future performance-based contingent payments for Bell Nursery, acquired in March 2018. The contingent period for Bell Nursery expired in December 2018. Performance thresholds that would have necessitated payment were not met, and accordingly, no payment was made. The fair value of the estimated contingent consideration arrangement is determined based on the Company’s evaluation as to the probability and amount of any earn-out that will be achieved based on expected future performance by the acquired entity. This is presented as part of long-term liabilities in the Company's consolidated balance sheets.
Summary of Changes in Fair Value of Level 3 Financial Instruments
The following table provides a summary of the changes in fair value of the Company's Level 3 financial instruments for the periods ended June 29, 2019 and June 30, 2018 (in thousands):
 
Amount
Balance September 29, 2018
$
8,224

Estimated contingent performance-based consideration established at the time of acquisition

Changes in the fair value of contingent performance-based payments established at the time of acquisition
(296
)
Performance-based payments
(104
)
Balance June 29, 2019
$
7,824

 
 
 
Amount
Balance September 30, 2017
$
9,343

Estimated contingent performance-based consideration established at the time of acquisition

Changes in the fair value of contingent performance-based payments established at the time of acquisition
(1,494
)
Performance-based payments
(204
)
Balance June 30, 2018
$
7,645